삼성서울병원

Ko En

Hematology-Oncology Kim, Ji Yeon M.D

Expertise
Breast Cancer, Chemotherapy, Targeted therapy, Systemic treatment
Treament Schedule 06 月
DATE
SAT
01
SUN
02
MON
03
TUE
04
WEB
05
THU
06
FRI
07
SAT
08
SUN
09
MON
10
TUE
11
WEB
12
THU
13
FRI
14
SAT
15
SUN
16
MON
17
TUE
18
WEB
19
THU
20
FRI
21
SAT
22
SUN
23
MON
24
TUE
25
WEB
26
THU
27
FRI
28
SAT
29
SUN
30
AM
PM
Treament Schedule 07 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
WEB
31
AM
PM

Medical Education

2014~2022 Ph.D. in Medicine Seoul National University Collage of Medicine, Korea
2004~2008 Medical Doctor Seoul National University Collage of Medicine, Korea
2001~2004 Bachelor Korea Advanced Institute of Science and Technology, Korea

Post-Graduate Training

Fellowship   2013~2015 Division of Hematology-oncology, Department of Internal Medicine, Seoul National University Hospital
Residency   2009~2013 Department of Internal Medicine, Seoul National University Hospital
Internship   2008~2009 Seoul National University Hospital

Professional Appointments

2020~Present Assistant Professor Division of Hematology-oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine
2015~2020 Clinical Instructor Division of Hematology-oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine

Professional Memberships

2010~Present Member Korean Society of Medical Oncology
2017~Present Member American Society of Clinical Oncology
2022~Present Member Committee of review, Korean Cancer Association

Selected Publications

  • FRONT ONCOL 2021 10.3389/fonc.2021.596364 Deep Learning-Based Prediction Model for Breast Cancer Recurrence Using Adjuvant Breast Cancer Cohort in Tertiary Cancer Center Registry Kim1, JY; Lee, YS; Yu, J; Park, Y; Lee, SK; Lee, M; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Kang, M; Im, YH
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.653243 The Role of Chemotherapy in Patients With HER2-Negative Isolated Locoregional Recurrence of Breast Cancer: A Multicenter Retrospective Cohort Study Lee1, K; Sim, SH; Kang, EJ; Seo, JH; Chae, H; Lee, KS; Kim, JY; Ahn, JS; Im, YH; Park, S; Park, YH; Park, IH
    View PubMed
  • DIAGNOSTICS 2021 10.3390/diagnostics11020370 Local Laboratory Testing of Germline BRCA Mutations vs. Myriad: A Single-Institution Experience in Korea Hong1, J; Lee, J; Kwon, M; Kim, JY; Kim, JW; Ahn, JS; Im, YH; Park, YH
    View PubMed
  • NAT COMMUN 2020 10.1038/s41467-020-19933-0 Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome Park1, YH; Lal, S; Lee, JE; Choi, YL; Wen, J; Ram, S; Ding, Y; Lee, SH; Powell, E; Lee, SK; Yu, JH; Ching, KA; Nam, JY; Kim, SW; Nam, SJ; Kim, JY; Cho, SY; Park, S; Kim, J; Hwang, S; Kim, YJ; Bonato, V; Fernandez, D; Deng, S; Wang, S; Shin, H; Kang, ES; Park, WY; Rejto, PA; Bienkowska, J; Kan, Z
    View PubMed
  • ANN TRANSL MED 2020 10.21037/atm-20-3466 Treatment strategy for papillary renal cell carcinoma type 2 a case series of seven patients treated based on next generation sequencing data Kim1, JY; Jeong, HO; Heo, DS; Keam, B; Moon, KC; Kwak, C; Jang, J; Kim, S; Kim, JI; Lee, S; Lee, SH
    View PubMed